Publications by authors named "Michael Dudley"

Claim this Profile
A
Ancestral β-globin gene haplotypes modify β-thalassemia severity in a mouse model.
Christophe Lechauve, Julia Keith, Michael W Dudley, Alfonso G Fernandez, Eugene Khandros

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient characteristics and health system encounters of decedents not marked deceased in the electronic health record.
Fernando Javier Sanz Vidorreta, Michael T Dudley, Anne M Walling, Chi-Hong Tseng, Michael Hogarth

JAMIA Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consequences of a Health System Not Knowing Which Patients Are Deceased.
Neil S Wenger, Fernando Javier Sanz Vidorreta, Michael T Dudley, Anne M Walling, Michael Hogarth

JAMA Intern Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjects.
María Patricia Hernández-Mitre, Steven C Wallis, Elizabeth E Morgan, Michael N Dudley, Jeffery S Loutit

Antimicrob Agents Chemother· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance and the delivery of healthcare in Australian immigration detention centres.
Ryan Essex, Michael Dudley

Monash Bioeth Rev· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
potency of xeruborbactam in combination with multiple β-lactam antibiotics in comparison with other β-lactam/β-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum β-lactamase-producing .
Olga Lomovskaya, Mariana Castanheira, Jill Lindley, Debora Rubio-Aparicio, Kirk Nelson, Michael Dudley

Antimicrob Agents Chemother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upgraded for rapid recognition and fitting of Laue patterns from crystals with unknown orientations.
Vincent W Huang, Yafei Liu, Balaji Raghothamachar, Michael Dudley

J Appl Crystallogr· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of miR-144/451 alleviates β-thalassemia by stimulating ULK1-mediated autophagy of free α-globin.
Julia Keith, Georgios E Christakopoulos, Alfonso G Fernandez, Yu Yao, Jingjing Zhang, Michael Dudley

Blood· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New boronate drugs and evolving NDM-mediated beta-lactam resistance.
Olga Lomovskaya, Ruslan Tsivkovski, Maxim Totrov, Dana Dressel, Mariana Castanheira, Michael Dudley

Antimicrob Agents Chemother· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Biapenem in Healthy Adult Subjects.
David C Griffith, Elizabeth E Morgan, Michael N Dudley, Jeffery S Loutit

Antimicrob Agents Chemother· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens.
Kade D Roberts, Yan Zhu, Mohammad A K Azad, Mei-Ling Han, Jiping Wang, Michael N Dudley

Nat Commun· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 Restores the Potency of Multiple Oral Beta-Lactam Antibiotics against Beta-Lactamase-Producing Strains of Resistant .
Olga Lomovskaya, Debora Rubio-Aparicio, Ruslan Tsivkovski, Jeff Loutit, Michael Dudley

Antimicrob Agents Chemother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of QPX7831, an Orally Bioavailable Prodrug of Boronic Acid β-Lactamase Inhibitor QPX7728.
K Raja Reddy, Jonathan Parkinson, Mojgan Sabet, Ziad Tarazi, Serge H Boyer, Michael N Dudley

J Med Chem· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics.
Olga Lomovskaya, Ruslan Tsivkovski, Dongxu Sun, Raja Reddy, Maxim Totrov, Michael Dudley

Front Microbiol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa.
Olga Lomovskaya, Debora Rubio-Aparicio, Kirk Nelson, Dongxu Sun, Ruslan Tsivkovski, Michael Dudley

Antimicrob Agents Chemother· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic modelling of Australian rooftop solar photovoltaic product stewardship transition.
Hengky K Salim, Rodney A Stewart, Oz Sahin, Michael Dudley

Waste Manag· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii.
Kirk Nelson, Debora Rubio-Aparicio, Ruslan Tsivkovski, Dongxu Sun, Maxim Totrov, Michael Dudley

Antimicrob Agents Chemother· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases.
Scott J Hecker, K Raja Reddy, Olga Lomovskaya, David C Griffith, Debora Rubio-Aparicio, Michael N Dudley

J Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of the Ultrabroad-Spectrum-Beta-Lactamase Inhibitor QPX7728 against Carbapenem-Resistant with Varying Intrinsic and Acquired Resistance Mechanisms.
Kirk Nelson, Debora Rubio-Aparicio, Dongxu Sun, Michael Dudley, Olga Lomovskaya

Antimicrob Agents Chemother· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum of Beta-Lactamase Inhibition by the Cyclic Boronate QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases: Enhancement of Activity of Multiple Antibiotics against Isogenic Strains Expressing Single Beta-Lactamases.
Olga Lomovskaya, Ruslan Tsivkovski, Kirk Nelson, Debora Rubio-Aparicio, Dongxu Sun, Michael N Dudley

Antimicrob Agents Chemother· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Intrinsic Resistance Mechanisms on Potency of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases in , Pseudomonas aeruginosa, and Acinetobacter baumannii.
Olga Lomovskaya, Kirk Nelson, Debora Rubio-Aparicio, Ruslan Tsivkovski, Dongxu Sun, Michael N Dudley

Antimicrob Agents Chemother· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis